Louiza S. Velentzis
YOU?
Author Swipe
View article: Risk-adjusted breast screening: an Australian perspective and considerations for the Western Pacific
Risk-adjusted breast screening: an Australian perspective and considerations for the Western Pacific Open
Breast cancer is the most common cancer in females globally, and the leading cause of female cancer deaths. The 2023 World Health Organisation Global Breast Cancer Initiative Framework aims to prevent 2·5 million deaths from breast cancer …
View article: Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010–2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening
Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010–2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening Open
This analysis demonstrates that the benefits of HPV vaccination programs extend beyond prevention of HPV-related disease. HPV vaccination will reduce PTBs and LBW infants, with a further reduction with future twice-lifetime screening for H…
View article: Participation in the National Cervical Screening Program Among Women Who Gave Birth in New South Wales, Australia by Place of Maternal Birth: A Data Linkage Analysis
Participation in the National Cervical Screening Program Among Women Who Gave Birth in New South Wales, Australia by Place of Maternal Birth: A Data Linkage Analysis Open
Objective High participation rates in the National Cervical Screening Program (NCSP) by all groups of women are required to ensure the equitable elimination of cervical cancer in Australia. In this study, we examine screening participation…
View article: Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a prospective cohort study
Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a prospective cohort study Open
Reduced priority of screening and heightened recent anxiety may partly explain indications of lower-than-expected cervical screening rates during the pandemic. It is important that catch-up of missed HPV screens is performed to prevent a p…
View article: A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination
A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination Open
COVID-19 disrupted school attendance in many countries, delaying routine adolescent vaccination against human papillomavirus (HPV) in some settings. We used Policy1-Cervix , a dynamic model simulating HPV transmission, natural history, vac…
View article: Author response: A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination
Author response: A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination Open
Full text Figures and data Side by side Abstract Editor's evaluation Introduction Results Discussion Methods Data availability References Decision letter Author response Article and author information Abstract COVID-19 disrupted school att…
View article: Incidence profile of four major cancers among migrants in Australia, 2005–2014
Incidence profile of four major cancers among migrants in Australia, 2005–2014 Open
Purpose To compare the incidence profile of four major cancers in Australia by place of birth. Methods In this retrospective population-based cohort study, the analysis included 548,851 residents diagnosed with primary colorectum, lung, fe…
View article: A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia
A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia Open
Australia introduced COVID-19 infection prevention and control measures in early 2020. To help prepare health services, the Australian Government Department of Health commissioned a modelled evaluation of the impact of disruptions to popul…
View article: Author response: A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia
Author response: A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia Open
Article Figures and data Abstract Editor's evaluation Introduction Methods Results Discussion Data availability References Decision letter Author response Article and author information Metrics Abstract Australia introduced COVID-19 infect…
View article: Female reproductive and hormonal factors and lung cancer mortality among never‐smokers: A prospective cohort study of 287 408 Chinese women
Female reproductive and hormonal factors and lung cancer mortality among never‐smokers: A prospective cohort study of 287 408 Chinese women Open
There is growing, but inconsistent evidence suggesting oestrogen may play a key role in lung cancer development, especially among never‐smoking women for whom lung cancer risk factors remain largely elusive. Using the China Kadoorie Bioban…
View article: A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination analysis
A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination analysis Open
COVID-19 disrupted school attendance in many countries, delaying routine adolescent vaccination against human papillomavirus (HPV) in some settings. We used the ‘ Policy1-Cervix’ HPV model (natural history/vaccination/screening/HPV-related…
View article: Breast Cancer Risk Assessment Tools for Stratifying Women into Risk Groups: A Systematic Review
Breast Cancer Risk Assessment Tools for Stratifying Women into Risk Groups: A Systematic Review Open
Background: The benefits and harms of breast screening may be better balanced through a risk-stratified approach. We conducted a systematic review assessing the accuracy of questionnaire-based risk assessment tools for this purpose. Method…
View article: Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening
Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening Open
Australia's cervical screening program transitioned from cytology to HPV-testing with genotyping for HPV16/18 in Dec'2017. We investigated whether program data could be used to monitor HPV vaccination program impact (commenced in 2007) on …
View article: The impact of COVID-19 on population cancer screening programs in Australia: modelled evaluations for breast, bowel and cervical cancer
The impact of COVID-19 on population cancer screening programs in Australia: modelled evaluations for breast, bowel and cervical cancer Open
Background Australia introduced COVID-19 infection prevention and control measures in early 2020. To help prepare health services the Australian Government Department of Health commissioned a modelled evaluation of the impact of disruption…
View article: BreastScreen Australia national data by factors of interest for risk‐based screening: routinely reported data and opportunities for enhancement
BreastScreen Australia national data by factors of interest for risk‐based screening: routinely reported data and opportunities for enhancement Open
Enhanced BreastScreen data collection and reporting would improve the evidence base and support evaluation of risk-based screening and improve the detail available for benchmarking any future changes to the program.
View article: The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes
The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes Open
While the benefits of human papillomavirus (HPV) vaccination relating to cervical cancer prevention have been widely documented, recent published evidence is suggestive of an impact on adverse pregnancy outcomes (APOs) in vaccinated mother…
View article: 965The estimated impact of improved breast screening tests targeted at women with dense breasts
965The estimated impact of improved breast screening tests targeted at women with dense breasts Open
Background There is increasing interest in risk-based breast cancer screening, including interventions to improve outcomes for women with mammographically dense breasts. Methods Policy1-Breast is a continuous-time, multiple-cohort micro-si…
View article: 704The preventable future burden of cancer in Australia
704The preventable future burden of cancer in Australia Open
Background Estimates of the future burden of invasive cancer attributable to current modifiable causal exposures can guide cancer prevention. Methods We linked pooled data from seven Australian cohort studies (N = 367,058) to national canc…
View article: 906Can mammographic density add value to the Gail model in risk-stratifying women in BreastScreen Australia?
906Can mammographic density add value to the Gail model in risk-stratifying women in BreastScreen Australia? Open
Background There is significant interest in personalised, risk-based breast cancer screening. This requires high quality risk assessment. The ‘Gail model’ risk assessment tool has been validated on over 40,000 BreastScreen Australia partic…
View article: Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study
Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study Open
Menopausal hormone therapy (MHT) is effective for menopausal symptoms, however, its use is also associated with risks of serious health conditions including breast, ovarian and endometrial cancer, stroke and venous thromboembolism. MHT-rel…
View article: Improving breast cancer screening in Australia: a public health perspective
Improving breast cancer screening in Australia: a public health perspective Open
There are currently no single disruptors to breast cancer screening akin to the impact of human papillomavirus testing and vaccination on cervical cancer screening. However, there is a groundswell of interest to review the BreastScreen Aus…
View article: Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions
Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions Open
Existing modalities can effectively treat high-grade cervical intraepithelial neoplasia (CIN) but around 7% of treated women will develop recurrence of CIN grade 2 or above within 2 years of treatment. Post-treatment surveillance is theref…
View article: The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study
The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study Open
Estimates of the future breast cancer burden preventable through modifications to current behaviours are lacking. We assessed the effect of individual and joint behaviour modifications on breast cancer burden for premenopausal and postmeno…
View article: Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening Open
This study demonstrates that the clinical sensitivity, specificity, and reproducibility of the novel cobas human papillomavirus (HPV) test on the cobas 6800 system for high-risk HPV types fulfills the criteria for use in population-based c…